Skip to content

Tempus Joins Parse Biosciences’ Certified Service Provider Network

By API User

Advancing multi-omics research by enabling Tempus’ data-driven expertise with Parse’s scalable single cell platform SEATTLE–BUSINESS WIRE– Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome Tempus as the newest member of its Certified Service Provider (CSP) Program. Together, the companies will broaden access to high-quality and scalable single cell … Continued

biomodal Launches Certified Service Provider Program for Duet Multiomics 5-Base and 6-Base Sequencing Solutions

By API User

CAMBRIDGE, England–BUSINESS WIRE– biomodal, an omics-based life sciences technology and analytics company, today announced it has launched a Certified Service Provider (CSP) program with partners around the globe to meet the increasing demand for its novel duet multiomics solutions. The organizations are partnering with biomodal as they work to deliver transformative data and insights for … Continued

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer

By API User

Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A financing led by … Continued

Starpharma Holdings (ASX: SPL) Announces License Agreement with Genentech

By API User

● Starpharma will employ its proprietary DEP® platform technology to develop dendrimerdrug conjugates that incorporate Genentech medicines for certain oncology targets. ● Starpharma will commence development activities immediately and work exclusively with Genentech in relation to those targets. ● Starpharma will receive an upfront payment of USD $5.5 million (~AUD $8.3 million), and is eligible … Continued

BioMedTech Incubator Program Delivered by Brandon BioCatalyst’s CUREator and CSIRO Opens New Funding Round

By API User

Wednesday 8 October 2025: The $33 million BioMedTech incubator (BMTI) program delivered by Brandon BioCatalyst’s CUREator has opened its first funding round and is seeking expressions of interest from early-stage Australian biotech startups developing novel therapies with strong commercial potential across the discovery, preclinical, and clinical development stages. Funded by the Australian Government’s $20 billion … Continued

Media Alert – Community Health in Focus: Community Health First Launches 2025 Impact Report

By API User

What:   Minister for Health, Hon Mary-Anne Thomas will speak at the launch of Community Health First 2025 Impact Report. The report showcases the critical role of community health in delivering equitable, accessible healthcare across Victoria.  When:  Tuesday 14 October 2025  3:00 pm – 4.30 pm   Where:  South Library Parliament House of Victoria  Spring St, … Continued

Nursing workforce reforms needed to support Thriving Kids initiative

By API User

Four peak nursing organisations have united to call for critical workforce reforms and sustainable funding models to ensure the success of the federal government’s Thriving Kids initiative.   The Australian College of Nursing (ACN), Australian College of Children & Young People’s Nurses (ACCYPN), Maternal, Child & Family Health Nurses Australia (MCaFHNA), and Professional Association of … Continued

Thriving at work: Free Mental Health Month Webinar for Employers and HR leaders

By API User

With one in two Australians experiencing a mental health condition in their lifetime and workplace stress a leading contributor, organisations are under growing pressure to rethink how they design work and support employees.   Rehab Management, one of Australia’s leading occupational rehabilitation and corporate health providers, will mark Mental Health Month with a free webinar … Continued

AI tool designed to identify buyer behaviour reimagined to discover medicine safety and repurposing opportunities

By API User

Monash University researchers are using the power of consumer AI to evaluate the safety and repurposing potential of medicines.The ‘association discovery’ data mining tool, known as Magnum Opus and typically used to pinpoint buyer behaviour patterns has been redefined to uncover patterns in medicine safety and drug discovery. The new study is published in Clinical … Continued